Stocks
Amgen Financial Statements (AMGN) |
||||||||||
| Amgensmart-lab.ru | % | 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 04.08.2023 | 31.10.2023 | 06.02.2024 | 14.02.2024 | 03.05.2024 | 03.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 6 986 | 6 903 | 8 196 | 8 196 | 7 396 | 30 691 | |||
| Operating Income, bln rub | 2 684 | 2 021 | 1 271 | 1 271 | 940.0 | 5 503 | ||||
| EBITDA, bln rub | ? | 2 366 | 2 706 | 1 271 | 3 053 | 2 339 | 9 369 | |||
| Net profit, bln rub | ? | 1 379 | 1 730 | 767.0 | 767.0 | -113.0 | 3 151 | |||
| OCF, bln rub | ? | 4 109 | 2 760 | 538.0 | 538.0 | 689.0 | 4 525 | |||
| CAPEX, bln rub | ? | 271.0 | 248.0 | 249.0 | 249.0 | 230.0 | 976.0 | |||
| FCF, bln rub | ? | 3 838 | 2 512 | 289.0 | 289.0 | 459.0 | 3 549 | |||
| Dividend payout, bln rub | 1 139 | 1 140 | 0.000 | 1 140 | 1 208 | 3 488 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 82.6% | 65.9% | 0.00% | 148.6% | 0.00% | 110.7% | ||||
| OPEX, bln rub | 2 489 | 3 076 | 3 813 | 3 813 | 3 256 | 13 958 | ||||
| Cost of production, bln rub | 1 813 | 1 806 | 3 112 | 3 112 | 3 200 | 11 230 | ||||
| R&D, bln rub | 1 113 | 1 079 | 1 534 | 1 534 | 1 343 | 5 490 | ||||
| Interest expenses, bln rub | 752.0 | 759.0 | 821.0 | 821.0 | 824.0 | 3 225 | ||||
| Assets, bln rub | 90 269 | 90 534 | 97 154 | 97 154 | 92 980 | 92 980 | ||||
| Net Assets, bln rub | ? | 6 781 | 7 656 | 6 232 | 6 232 | 5 022 | 5 022 | |||
| Debt, bln rub | 61 544 | 60 468 | 64 613 | 64 613 | 64 020 | 64 020 | ||||
| Cash, bln rub | 34 248 | 34 741 | 10 944 | 10 944 | 9 708 | 9 708 | ||||
| Net debt, bln rub | 27 296 | 25 727 | 53 669 | 53 669 | 54 312 | 54 312 | ||||
| Ordinary share price, rub | 222.0 | 268.8 | 288.0 | 288.0 | 284.3 | 268.0 | ||||
| Number of ordinary shares, mln | 535.0 | 535.0 | 535.0 | 535.0 | 536.0 | 536.0 | ||||
| Market cap, bln rub | 118 781 | 143 787 | 154 091 | 154 091 | 152 396 | 143 659 | ||||
| EV, bln rub | ? | 146 077 | 169 514 | 207 760 | 207 760 | 206 708 | 197 971 | |||
| Book value, bln rub | -23 383 | -21 003 | -45 038 | -45 038 | -44 920 | -44 920 | ||||
| EPS, rub | ? | 2.58 | 3.23 | 1.43 | 1.43 | -0.21 | 5.88 | |||
| FCF/share, rub | 7.17 | 4.70 | 0.54 | 0.54 | 0.86 | 6.62 | ||||
| BV/share, rub | -43.7 | -39.3 | -84.2 | -84.2 | -83.8 | -83.8 | ||||
| EBITDA margin, % | ? | 33.9% | 39.2% | 15.5% | 37.2% | 31.6% | 30.5% | |||
| Net margin, % | ? | 19.7% | 25.1% | 9.36% | 9.36% | -1.53% | 10.3% | |||
| FCF yield, % | ? | 8.15% | 6.52% | 4.94% | 4.78% | 4.66% | 2.47% | |||
| ROE, % | ? | 117.7% | 98.8% | 107.8% | 107.8% | 74.9% | 62.7% | |||
| ROA, % | ? | 8.84% | 8.36% | 6.91% | 6.91% | 4.05% | 3.39% | |||
| P/E | ? | 14.9 | 19.0 | 22.9 | 22.9 | 40.5 | 45.6 | |||
| P/FCF | 12.3 | 15.3 | 533.2 | 20.9 | 21.5 | 40.5 | ||||
| P/S | ? | 4.47 | 5.36 | 5.47 | 5.47 | 5.17 | 4.68 | |||
| P/BV | ? | -5.08 | -6.85 | -3.42 | -3.42 | -3.39 | -3.20 | |||
| EV/EBITDA | ? | 13.0 | 15.1 | 20.1 | 17.2 | 19.8 | 21.1 | |||
| Debt/EBITDA | 2.42 | 2.29 | 5.20 | 4.43 | 5.19 | 5.80 | ||||
| R&D/CAPEX, % | 410.7% | 435.1% | 616.1% | 616.1% | 583.9% | 562.5% | ||||
| CAPEX/Revenue, % | 3.88% | 3.59% | 3.04% | 3.04% | 3.11% | 3.18% | ||||
| Amgen shareholders | ||||||||||
